Clozapine. A novel antipsychotic agent. [N Engl J Med. 1991] - PubMed

loading

Review Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder. [CNS Drugs. 2003]
Review Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.
Wagstaff A, Perry C. CNS Drugs. 2003; 17(4):273-80; discussion 281-3.
Review Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions. [Child Adolesc Psychiatr Clin N...]
Review Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions.
Kranzler HN, Kester HM, Gerbino-Rosen G, Henderson IN, Youngerman J, Beauzile G, Ditkowsky K, Kumra S. Child Adolesc Psychiatr Clin N Am. 2006 Jan; 15(1):135-59.
Clozapine for treatment of schizophrenia. [JAMA. 1996]
Clozapine for treatment of schizophrenia.
Orr RD. JAMA. 1996 Jan 17; 275(3):186-7.
Review [Clozapine--an atypical neuroleptic with a unique clinical profile]. [Lakartidningen. 1992]
Review [Clozapine--an atypical neuroleptic with a unique clinical profile].
Lindström L, Lundberg T. Lakartidningen. 1992 Jun 24; 89(26-27):2368-72.
Modafinil and antipsychotic-induced sedation. [J Clin Psychiatry. 2004]
Modafinil and antipsychotic-induced sedation.
DeQuardo JR. J Clin Psychiatry. 2004 Feb; 65(2):278-9; author reply 279.

Aripiprazole-induced seizure: a second case report. [BMJ Case Rep. 2009]
Aripiprazole-induced seizure: a second case report.
Yueh CL, Yu SL, Chen HM, Wu BJ, Chen WC. BMJ Case Rep. 2009; 2009. Epub 2009 Jul 14.
Functional division of hippocampal area CA1 via modulatory gating of entorhinal cortical inputs. [Hippocampus. 2012]
Functional division of hippocampal area CA1 via modulatory gating of entorhinal cortical inputs.
Ito HT, Schuman EM. Hippocampus. 2012 Feb; 22(2):372-87. Epub 2011 Jan 14.
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. [Eur Neuropsychopharmacol. 2010]
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
Semenova S, Markou A. Eur Neuropsychopharmacol. 2010 Oct; 20(10):731-46. Epub 2010 Jun 3.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Clozapine. A novel antipsychotic agent.
Clozapine. A novel antipsychotic agent.
N Engl J Med. 1991 Mar 14 ;324(11):746-54.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed